Table 2. Univariate and Multivariate analysis of clinical parameters in relation to overall survival.
Univariate | Multivariate | |||
---|---|---|---|---|
Variables | HR (95%CI) | P | R (95%CI) | P |
miR-26a expression | 3.732 (1.814–6.421) | 0.031* | 3.461(1.331–5.364) | 0.013* |
Age at diagnosis | 1.515 (0.574–1.842) | 0.583 | 1.215(0.609–2.074) | 0.437 |
Gender | 1.936 (0.762–2.452) | 0.678 | 1.548 (0.652–2.115) | 0.547 |
Clinical stage at diagnosis | 3.547 (1.427–4.416) | 0.015* | 3.112 (1.268–3.709) | <0.001* |
Invasion depth | 2.615 (0.894–3.431) | 0.106 | 2.314 (0.852–2.472) | 0.0891 |
Lymph vessel infiltration | 3.462 (2.134–5.383) | 0.031* | 2.953 (2.141–3.458) | 0.007* |
Distant metastasis | 2.784 (1.487–4.125) | 0.017* | 3.456 (1.424–6.135) | 0.008* |
Differentiation | 4.193 (2.216–7.146) | 0.002* | 2.986 (1.897–4.116) | 0.017* |
CI: confidence interval; HR: hazard ratio
Significant relation of clinical factors with overall survival